Karen Lewis Moynihan

Title: Karen Lewis Moynihan: Innovator in Liposomal Drug Formulations

Introduction

Karen Lewis Moynihan is a prominent inventor based in Redlands, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the efficacy of anti-tumor agents through advanced delivery systems.

Latest Patents

Karen holds a patent for liposomal camptothecin formulations. This patent describes liposomal encapsulated camptothecin formulations that exhibit improved pharmacokinetics and enhanced efficacy as anti-tumor agents. The liposomes utilized in her formulations comprise at least one phospholipid and a camptothecin or an analog thereof. These advancements provide an increased therapeutic index compared to the free drug and topotecan.

Career Highlights

Karen is associated with Osi Pharmaceuticals, Inc., where she has been instrumental in the research and development of novel pharmaceutical products. Her expertise in liposomal formulations has positioned her as a key figure in the industry, contributing to the advancement of cancer treatment options.

Collaborations

Throughout her career, Karen has collaborated with notable professionals in her field, including David Lloyd Emerson and Su-Ming Chiang. These partnerships have fostered innovation and have been vital in the progression of her research endeavors.

Conclusion

Karen Lewis Moynihan's work in liposomal drug formulations represents a significant advancement in cancer therapeutics. Her innovative approach continues to influence the pharmaceutical industry and improve treatment outcomes for patients.